Arginine vasopressin inhibits Kir6.1/SUR2B channel and constricts the mesenteric artery via V1a receptor and protein kinase C

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 293, Issue 1, 2007, Pages

  Shi, Weiwei ^a   Cui, Ningren ^a   Shi, Yun ^a   Zhang, Xiaoli ^a   Yang, Yang ^a   Jiang, Chun ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Antagonist; K+ channel; Phosphorylation; Second messenger; Vascular tones

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARGIPRESSIN; GLIBENCLAMIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL KIR6.1; PHORBOL ESTER; PINACIDIL; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG; VASOPRESSIN V1A RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CELL MEMBRANE POTENTIAL; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MESENTERIC ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VOLTAGE CLAMP; WHOLE CELL;

ALGORITHMS; ARGININE VASOPRESSIN; CELL LINE; ENZYME INHIBITORS; GLYBURIDE; HUMANS; MESENTERIC ARTERIES; MYOCYTES, SMOOTH MUSCLE; NAPHTHALENES; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN KINASE C; RECEPTORS, VASOPRESSIN; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 34447622269     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00047.2007     Document Type: Article

References (43)

1. Bankir L. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Cardiovasc Res 51: 372-390, 2000.
2. Birnbaumer M. Vasopressin receptors. Trends Endocrinol Metab 11: 406-410, 2000.
3. + channels in arterial smooth muscle through protein kinase C. J Gen Physiol 108: 315-323, 1996.
4. Brueggemann LI, Martin BL, Barakat J, Byron KL, Cribbs LL. Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking. Am J Physiol Heart Circ Physiol 288: H923-H935, 2005.
5. ATP channels. J Clin Invest 110: 203-208, 2002.
6. Dumont E, Lamontagne D. No role of ATP-sensitive potassium channels in the vasoconstriction produced by vasopressin. J Vasc Res 32: 138-142, 1995.
7. Eatman D, Stallone JN, Rutecki GW, Whittier FC. Sex differences in extracellular and intracellular calcium-mediated vascular reactivity to vasopressin in rat aorta. Eur J Pharmacol 361: 207-216, 1998.
8. Folny V, Raufaste D, Lukovic L, Pouzet B, Rochard P, Pascal M, Serradeil-Le GC. Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas. Am J Physiol Endocrinol Metab 285: E566-E576, 2003.
9. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med 26: 2078-2086, 1998.
10. Garcia-Villalon AL, Padilla J, Monge L, Fernandez N, Sanchez MA, Gomez B, Dieguez G. Effects of vasopressin on the sympathetic contraction of rabbit ear artery during cooling. Br J Pharmacol 126: 785-793, 1999.
11. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1-receptor physiology. Crit Care 7: 427-434, 2003.
12. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 120: 989-1002, 2001.
13. Howl J, Wheatley M. Molecular pharmacology of V1a vasopressin receptors. Gen Pharmacol 26: 1143-1152, 1995.
14. Hu K, Huang CS, Jan YN, Jan LY. ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C. Neuron 38: 417-432, 2003.
15. Innamorati G, Sadeghi HM, Tran NT, Birnbaumer M. A serine cluster prevents recycling of the V2 vasopressin receptor. Proc Natl Acad Sci USA 95: 2222-2226, 1998.
16. + channel Kir6.1. J Physiol 508: 23-30, 1998.
17. ATP mutant mice arises from a smooth muscle-extrinsic process. Circ Res 98: 682-689, 2006.
18. Katori E, Ohta T, Nakazato Y, Ito S. Vasopressin-induced contraction in the rat basilar artery in vitro. Eur J Pharmacol 416: 113-121, 2001.
19. + channel. J Biol Chem 277: 21346-21351, 2002.
20. + currents in rat arterial smooth muscle cells through protein kinase C. J Physiol 503: 489-496, 1997.
21. 2+ concentration in insulin-secreting cells. EMBO J 8: 3595-3599, 1989.
22. Maruyama Y, Nakanishi Y, Walsh EJ, Wilson DP, Welsh DG, Cole WC. Heteromultimeric TRPC6-TRPC7 channels contribute to arginine vasopressin-induced cation current of A7r5 vascular smooth muscle cells. Circ Res 98: 1520-1527, 2006.
23. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8: 466-472, 2002.
24. Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med 30: 1276-1291, 2004.
25. + channels. Nature 344: 770-773, 1990.
26. Newton AC. Protein kinase C: structure function, regulation. J Biol Chem 270: 28495-28498, 1995.
27. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77: 1165-1232, 1997.
28. + channels? Circ Res 93: 646-655, 2003.
29. + channel. Circ Res 94: 1359-1366, 2004.
30. Sampson LJ, Hayabuchi Y, Standen NB, Dart C. Caveolae localize protein kinase A signaling to arterial ATP-sensitive potassium channels. Circ Res 95: 1012-1018, 2004.
31. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Parsonnet J, Panzer R, Orav EJ, Snydman DR, Black E, Schwartz JS, Moore R, Johnson BL Jr, Platt R. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278: 234-240, 1997.
32. Stam WB, Van der Graaf PH, Saxena PR. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin. Br J Pharmacol 125: 865-873, 1998.
33. + channels in smooth muscle. J Physiol 572: 617-624, 2006.
34. Terrillon S, Barberis C, Bouvier M. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with β-arrestin and their trafficking patterns. Proc Natl Acad Sci USA 101: 1548-1553, 2004.
35. + channels composed of Kir6.1 and/or Kir6.2 expressed with SUR2B. J Physiol 541: 65-80, 2002.
36. + channels via V1 receptors activation in the guinea pig heart. Circ J 66: 277-282, 2002.
37. 2+ current activated by vasoconstrictors in vascular smooth muscle cells. Pflügers Arch 429: 1-6, 1994.
38. +-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol Heart Circ Physiol 263: H491-H496, 1992.
39. ATP channels in vascular smooth muscles. Circ Res 92: 1225-1232, 2003.
40. Wareing M, Greenwood SL, Fyfe GK, Baker PN, Taggart MJ. Glibenclamide inhibits agonist-induced vasoconstriction of placental chorionic plate arteries. Placenta 27: 660-668, 2006.
41. + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 507: 117-129, 1998.
42. ATP channels underlie endotoxin-induced smooth muscle hyperpolarization in rat mesenteric resistance arteries. Br J Pharmacol 142: 479-484, 2004.
43. + channel. J Physiol 499: 715-720, 1997.